| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.084 | 0.05 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |